Key result
Catheter ablation eliminates donor-derived WPW syndrome in a heart transplant recipient with zero 2-year recurrence.
Why the study?
Wolff-Parkinson-White syndrome occurrence and management in heart transplant recipients is not well characterized.
Case Report (n=1)
No
Ventricular pre-excitation in a donor heart should not contraindicate transplantation, as it can be successfully managed with catheter ablation in the recipient.
Supports ablation feasibility for donor-derived WPW post-transplant; hypothesis-generating and requires prospective confirmation before practice change.
A 44-year-old woman underwent heart transplantation due to refractory angina and advanced heart failure.During the postoperative period, she developed episodes of supraventricular tachycardia and intermittent ventricular pre-excitation on the electrocardiogram.After an initial period of pharmacological management, she underwent successful radiofrequency ablation of a left posteroseptal accessory pathway.A review of the literature regarding Wolff-Parkinson-White syndrome in heart transplant recipients is also presented.
No takes yet. Share an insight, caveat, or question.
Schreiber et al. (2026) conducted a case report in Wolff-Parkinson-White Syndrome (n=1). Radiofrequency catheter ablation was evaluated on Freedom from supraventricular tachycardia and pre-excitation. Radiofrequency catheter ablation successfully treated donor-derived Wolff-Parkinson-White syndrome in a heart transplant recipient, with no recurrence of arrhythmias over 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: